New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. META
4. DPZ
5. IBM
6. CNC
7. KFY
8. SPY
9. MU
10. ENRD

Go back to New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide
Amgen Inc (NASDAQ: AMGN) Delayed: 344.72 --0 (-0%)
Previous Close $344.72    52 Week High $176.85 
Open $344.72    52 Week Low $133.64 
Day High $344.72    P/E 51.92 
Day Low $344.72    EPS $6.64 
Volume 5,091       

(NYSE: UCB) Delayed: 33.38 --0 (-0%)
Previous Close $33.38    52 Week High $ 
Open $33.38    52 Week Low $ 
Day High $33.38    P/E N/A 
Day Low $33.38    EPS $ 
Volume 1,535       

UCB Unsponsored ADR (AMEX: UCBJY) Delayed: 141.43 --0 (-0%)
Previous Close $141.43    52 Week High $46.25 
Open $141.43    52 Week Low $32.74 
Day High $141.43    P/E N/A 
Day Low $141.43    EPS $0.00 
Volume 11